Medtronic launches resorbable spinal plate
This article was originally published in Clinica
Medtronic has introduced in the US spinal fusion market, the first resorbable plate designed for use as a bone graft containment system. The Mystique plate, which is composed of the company's hydrosorb PLDLA co-polymer technology, helps stabilise weak bone tissue and prevent bone graft dislodgement following an anterior cervical discectomy and fusion. The plate dissolves within 18 to 36 months after insertion, the company said; traditional plates are made of metal.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.